Faraz Ali - 15 Feb 2022 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role: Chief Executive Officer, Director
Signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Issuer symbol: TNYA
Transactions as of: 15 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 17 Feb 2022, 16:45:26 UTC
Previous filing: 29 Jul 2021
Next filing: 17 Feb 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNYA	Stock Option (Right to buy)	Award	$0	+401,390		$0.000000	401,390	15 Feb 2022	Common Stock	401,390	$15.19	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one (1) month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.

Content

Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one (1) month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.